How do immune checkpoint-targeted antibodies work? The need for improved pharmacokinetic evaluation in early phase studies / Ascierto, P. - In: ANNALS OF ONCOLOGY. - ISSN 0923-7534. - 29:11(2018), pp. 2157-2160. [10.1093/annonc/mdy420]

How do immune checkpoint-targeted antibodies work? The need for improved pharmacokinetic evaluation in early phase studies

Ascierto P
2018

2018
How do immune checkpoint-targeted antibodies work? The need for improved pharmacokinetic evaluation in early phase studies / Ascierto, P. - In: ANNALS OF ONCOLOGY. - ISSN 0923-7534. - 29:11(2018), pp. 2157-2160. [10.1093/annonc/mdy420]
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11588/1014417
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 2
  • ???jsp.display-item.citation.isi??? 1
social impact